IgE相关性疾病诊断与鉴别诊断的中国专家共识

标题: IgE相关性疾病诊断与鉴别诊断的中国专家共识
title: Chinese Expert Consensus on the Diagnosis and Differential Diagnosis of IgE-Related Diseases
版本: 原创版
version: Original
分类: 专家共识
classification: Experts consensus
领域: 诊断
field: Diagnosis
国家和地区: 中国
Country and region: China
指南使用者:
Guide users:
证据分级方法: 本专家共识将采用推荐分级的评估、制订与评价(GRADE)系统进行证据分级,并基于证据级别形成推荐意见。
Evidence grading method: The Grading of Recommendations, Assessment, Development and Evaluations (GRADE) system will be used to rate the evidence that forms the basis for the recommendations in the expert consensus.
制定单位: 广州医科大学附属第一医院国家呼吸医学中心
Formulating unit: The First Affiliated Hospital of Guangzhou Medical University National Center for Respiratory Medicine
注册时间: 2024-11-04
Registration time:
注册编号: PREPARE-2024CN026
Registration number:
指南制订的目的: 近年来,随着专家学者对多种疾病的生理病理机制进一步探索,发现IgE在过敏性疾病、自身免疫性疾病、感染性疾病、同种异体移植、恶性肿瘤等许多疾病的发生发展过程中均有重要作用。但目前临床医生对IgE相关疾病的了解不足,在诊断与管理方面更加缺乏经验。为提升临床对IgE相关疾病的诊断和鉴别诊断能力,我国呼吸、感染、免疫、变态反应等领域的专家们共同编写了本共识,就IgE相关疾病的发病机制与特征、IgE相关疾病的诊断和评估以及治疗原则进行归纳整理,并根据最新的研究证据提出了推荐意见,希望优化对IgE相关疾病患者的临床实践。
Purpose of the guideline: In recent years, with the further exploration of the physiological and pathological mechanisms of various diseases, it has been found that IgE plays an important role in the occurrence and development of many diseases such as allergic diseases, autoimmune diseases, infectious diseases, allogeneic transplantation, and malignant tumors. However, clinicians do not have sufficient understanding of IgE-related diseases and are even more inexperienced in diagnosis and management. In order to improve the clinical diagnosis and differential diagnosis of IgE-related diseases, experts in the fields of respiratory, infection, immunity, and allergy in China jointly compiled this consensus, summarized the pathogenesis and characteristics of IgE-related diseases, the diagnosis and evaluation of IgE-related diseases, and the treatment principles, and put forward recommendations based on the latest research evidence, hoping to optimize the clinical practice of patients with IgE-related diseases.